In ₹ Crore except Per Share 12 Months Ending | Q2 FY24 30/09/2023 | Q3 FY24 31/12/2023 | Q4 FY24 31/03/2024 | Q1 FY25 30/06/2024 | Q2 FY25 30/09/2024 | Q3 FY25 31/12/2024 | Q4 FY25 31/03/2025 | Q1 FY26 30/06/2025 | Q2 FY26 30/09/2025 | Q3 FY26 31/12/2025 | Q4 FY26 31/03/2026 | Q1 FY27 30/06/2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | 656.5 | 618.6 | 740.1 | 604.5 | 622.1 | 577.7 | 719.7 | 580.4 | 594.6 | 573.3 | 850.1 | 609.4 | |
| Other Income | 4.0 | 3.0 | 5.3 | 2.6 | 3.9 | 1.5 | 5.7 | 2.7 | 1.6 | 1.9 | 4.6 | 4.0 | |
| Total Income | 660.4 | 621.6 | 745.5 | 607.0 | 626.0 | 579.2 | 725.4 | 583.2 | 596.2 | 575.2 | 854.7 | 613.4 | |
| Expenses | |||||||||||||
| + Cost of Materials Consumed | 421.8 | 422.7 | 460.3 | 474.6 | 459.7 | 464.2 | 476.6 | 433.3 | 437.6 | 379.2 | 554.2 | 487.8 | |
| + Purchases of Stock-in-Trade | 18.8 | 24.7 | 22.6 | 13.5 | 28.7 | 34.6 | 23.2 | 17.4 | 13.2 | 11.4 | 24.8 | 15.7 | |
| + Changes in Inventories | 10.5 | -15.7 | 39.5 | -51.2 | -34.2 | -46.1 | 40.3 | -18.4 | -24.2 | 39.3 | 26.7 | -100.8 | |
| + Employee Benefit Expense | 40.5 | 37.3 | 37.9 | 38.2 | 44.6 | 45.0 | 46.4 | 41.3 | 44.9 | 47.2 | 50.8 | 50.9 | |
| + Finance Costs | 0.7 | 2.7 | 1.4 | 1.4 | 1.6 | 3.2 | 3.3 | 5.2 | 4.5 | -3.8 | 4.3 | 3.2 | |
| + Depreciation & Amortisation | 22.5 | 22.9 | 23.9 | 25.7 | 27.6 | 26.4 | 27.3 | 30.7 | 32.5 | 33.6 | 34.3 | 35.0 | |
| + Other Expenses | 70.7 | 74.1 | 87.6 | 71.0 | 77.6 | 77.0 | 78.3 | 67.3 | 68.0 | 68.2 | 84.0 | 78.7 | |
| Total Expenses | 585.5 | 568.6 | 673.1 | 573.4 | 605.6 | 604.4 | 695.4 | 576.8 | 576.4 | 575.2 | 779.0 | 570.5 | |
| EBITDA | 94.2 | 75.7 | 92.3 | 58.3 | 45.7 | 3.0 | 54.8 | 39.6 | 55.1 | 27.9 | 109.6 | 77.2 | |
| EBIT | 71.6 | 52.8 | 68.4 | 32.5 | 18.1 | -23.5 | 27.6 | 8.8 | 22.6 | -5.7 | 75.3 | 42.1 | |
| Profit | |||||||||||||
| PBT before Exceptional Items | 74.9 | 53.1 | 72.3 | 33.7 | 20.4 | -25.2 | 29.9 | 6.4 | 19.8 | 0.0 | 75.6 | 42.9 | |
| + Exceptional Items | 17.9 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -2.0 | 0.0 | 0.0 | |
| Pretax Income | 92.8 | 53.1 | 72.3 | 33.7 | 20.4 | -25.2 | 29.9 | 6.4 | 19.8 | -2.0 | 75.6 | 42.9 | |
| + Current Tax | 17.9 | 14.4 | 16.2 | 9.0 | 5.7 | -4.6 | 5.5 | 1.0 | 3.9 | -0.1 | 16.8 | 12.4 | |
| + Deferred Tax | 4.3 | 1.0 | 1.5 | 0.0 | 0.0 | -0.1 | 0.3 | 0.6 | 1.2 | 0.5 | 2.7 | -3.2 | |
| Tax Expense | 22.2 | 15.4 | 17.7 | 9.0 | 5.7 | -4.8 | 5.8 | 1.5 | 5.1 | 0.4 | 19.5 | 9.1 | |
| Net Income | 70.6 | 37.6 | 54.7 | 24.7 | 14.7 | -20.4 | 24.2 | 4.8 | 14.6 | -2.4 | 56.1 | 33.7 | |
| + Net Income — Continuing Ops | 70.6 | 37.6 | 54.7 | 24.7 | 14.7 | -20.4 | 24.2 | 4.8 | 14.6 | -2.4 | 56.1 | 33.7 | |
| + Other Comprehensive Income | -5.7 | 0.0 | 3.6 | 0.0 | -0.2 | 0.0 | 0.2 | 0.0 | 0.1 | 0.5 | -0.2 | 0.0 | |
| Total Comprehensive Income | 65.0 | 37.6 | 58.3 | 24.7 | 14.5 | -20.4 | 24.3 | 4.8 | 14.7 | -1.9 | 55.9 | 33.7 | |
| Per Share | |||||||||||||
| Basic EPS | 5.18 | 3.40 | 4.94 | 2.23 | 1.33 | -1.85 | 2.19 | 0.44 | 1.32 | -0.21 | 5.07 | 3.05 | |
| Diluted EPS | 5.18 | 3.40 | 4.94 | 2.23 | 1.33 | -1.85 | 2.19 | 0.44 | 1.32 | -0.21 | 5.07 | 3.05 | |
| Other Comprehensive Income — detail | |||||||||||||
| + Other Comprehensive Income | — | — | — | — | — | — | 0.2 | — | 0.1 | 0.5 | -0.2 | — | |
| + Items NOT to be Reclassified to P&L | -7.6 | 0.0 | 4.9 | — | -0.3 | 0.0 | 0.2 | — | 0.1 | 0.7 | -0.3 | — | |
| + Tax on Items NOT to be Reclassified | — | — | — | — | — | — | 0.1 | — | 0.0 | 0.2 | -0.1 | — | |
| + Tax on Items NOT to be Reclassified — alt tag | -1.9 | 0.0 | 1.3 | 0.0 | -0.1 | 0.0 | — | — | — | — | — | — | |
| Per Share — as-filed variants | |||||||||||||
| Basic EPS — Continuing Operations | 5.18 | 3.40 | 4.94 | 2.23 | 1.33 | -1.85 | 2.19 | 0.44 | 1.32 | -0.21 | 5.07 | 3.05 | |
| Diluted EPS — Continuing Operations | 5.18 | 3.40 | 4.94 | 2.23 | 1.33 | -1.85 | 2.19 | 0.44 | 1.32 | -0.21 | 5.07 | 3.05 | |
| Regulatory Disclosures — filed alongside, not part of the P&L | |||||||||||||
| Related-party Transactions — During the Period | — | — | — | — | — | — | -0.6 | — | 17.8 | — | 15.5 | — | |
| Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories) | |||||||||||||
| Gross Profit | 205.4 | 187.0 | 217.7 | 167.5 | 167.9 | 125.0 | 179.6 | 148.2 | 168.0 | 143.3 | 244.4 | 206.7 | |
| Gross Margin % | 31.28 | 30.23 | 29.42 | 27.71 | 26.99 | 21.64 | 24.96 | 25.53 | 28.26 | 25.00 | 28.75 | 33.92 | |
| Adjusted (ex-Exceptional Items) — derived | |||||||||||||
| Pretax Income (Adjusted, as filed) | 74.9 | 53.1 | 72.3 | 33.7 | 20.4 | -25.2 | 29.9 | 6.4 | 19.8 | 0.0 | 75.6 | 42.9 | |
| − Exceptional Items (reconciliation) | 17.9 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -2.0 | 0.0 | 0.0 | |
| Net Income Adj (tax-effected) | 57.0 | 37.6 | 54.7 | 24.7 | 14.7 | -20.4 | 24.2 | 4.8 | 14.6 | -0.3 | 56.1 | 33.7 | |
| EPS Adj | 4.18 | 3.40 | 4.94 | 2.23 | 1.33 | -1.85 | 2.19 | 0.44 | 1.32 | -0.03 | 5.07 | 3.05 | |
| Other Filed Concepts — mapped but not yet placed in the schedule | |||||||||||||
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | |
| Paid Up Equity Capital | 110.6 | 110.6 | 110.6 | 110.6 | 110.6 | 110.6 | 110.6 | 110.6 | 110.6 | 110.6 | 110.6 | 110.6 | |